Companies: 10,795·Total market cap: $144.5T
Almirall, S.A.

Almirall, S.A.

LBTSFOTCHealthcare
$15.35
$-0.12(-0.78%)
Market Cap$3.3B
P/E Ratio
52W High$15.47
52W Low$9.01
Overview

Almirall, S.A. (LBTSF) Revenue

Annual & quarterly revenue history · segment & region breakdown

LBTSF · revenue · updated Jun 8, 2026

Core revenue metrics

Almirall, S.A. trailing twelve-month (TTM) revenue is $1.37B, an increase of 12.37% year-over-year from $1.11B in FY2025.

TTM revenue
$1.37B
4-quarter sum · USD
YoY growth
+12.37%
vs FY2025 $1.11B
Price / sales
2.40×
mktCap ÷ TTM rev
Revenue per day
$4M
Est. TTM ÷ 365
Revenue / employee
$678K
2026 employees
FY2025
$1.11B
FY2024
$0.99B
5Y CAGR
+6.0%
Fiscal year end
Dec 31
Currency
EUR · GAAP
Filing
10-K / 10-Q
Source: FMP · Almirall, S.A. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$1.11B+$0.12B+12.37%
2024-12-31$0.99B+$0.09B+10.20%
2023-12-31$0.89B+$0.03B+3.62%
2022-12-31$0.86B+$0.04B+4.36%
2021-12-31$0.83B-$0.79B-48.78%
2020-12-31$1.61B+$0.76B+88.80%
2019-12-31$0.86B+$0.10B+13.00%
2018-12-31$0.76B+$0.12B+18.39%
2017-12-31$0.64B-$0.12B-16.35%
2016-12-31$0.76B+$0.08B+10.90%
LBTSF revenue by year · LBTSF revenue history · LBTSF annual revenue data

Compare revenue vs peers

Drug Manufacturers - Specialty & Generic

Compare LBTSF revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Almirall, S.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Almirall, S.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.

Data sourced from Almirall, S.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LBTSF revenue · 4 questions

LBTSF's trailing twelve-month (TTM) revenue is $1.37B. That is an increase of 12.37% year-over-year from $1.11B in FY2025.

LBTSF revenueLBTSF annual revenuewhat is LBTSF revenueLBTSF TTM revenue

Source: FMP · Almirall, S.A. SEC filings · GAAP · Almirall, S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026